Companies that work on treatments and vaccines for COVID-19 have been rewarded handsomely by investors in the past months and NanoViricides (NYSE: NNVC) seems to be the latest company to reap the rewards.
The NNVC stock rocketed by as cosmic as 57.50% on Tuesday after the company announced positive results with regards to its candidates for treating coronavirus patients. The biggest news is with regards to the product NV-CoV2.
NanoViricides revealed that the product, which has been manufactured using the company’s proprietary platform, is expected to be effective against the majority of the coronavirus strains. This is an important thing to keep in mind considering the fact that several new strains have emerged in recent times. On the other hand, NanoViricides also announced that the product proved to be considered effective against the coronavirus when compared to remdesivir. In such a situation, it is easy to see why investors seem to be highly optimistic about the prospects of the NanoViricides stock.
Finance and Entertainment Reporter
Richard is a bottle of wine – the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.